P. Hanjani

1.3k total citations
32 papers, 923 citations indexed

About

P. Hanjani is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Epidemiology. According to data from OpenAlex, P. Hanjani has authored 32 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Reproductive Medicine, 10 papers in Obstetrics and Gynecology and 9 papers in Epidemiology. Recurrent topics in P. Hanjani's work include Ovarian cancer diagnosis and treatment (11 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Cervical Cancer and HPV Research (6 papers). P. Hanjani is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Cervical Cancer and HPV Research (6 papers). P. Hanjani collaborates with scholars based in United States, Iran and United Kingdom. P. Hanjani's co-authors include Harrison Ball, J A Blessing, Stephen Williams, S Y Liao, Sandra Nolte, Ernestine Delmoor, Caryn Lerman, Suzanne M. Miller, P Engstrom and Maurie Markman and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

P. Hanjani

32 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Hanjani United States 15 414 351 236 178 164 32 923
Katina Robison United States 18 452 1.1× 266 0.8× 192 0.8× 351 2.0× 129 0.8× 75 1.1k
L. Elit Canada 18 494 1.2× 202 0.6× 365 1.5× 357 2.0× 203 1.2× 57 1.2k
Sarikapan Wilailak Thailand 16 311 0.8× 204 0.6× 242 1.0× 305 1.7× 120 0.7× 59 870
Teresa Díaz-Montes United States 22 657 1.6× 500 1.4× 306 1.3× 443 2.5× 119 0.7× 62 1.3k
Charlotte Gerd Hannibal Denmark 18 551 1.3× 174 0.5× 172 0.7× 266 1.5× 106 0.6× 34 842
Berit Jul Mosgaard Denmark 18 810 2.0× 388 1.1× 255 1.1× 432 2.4× 81 0.5× 45 1.2k
Corrado Terranova Italy 23 672 1.6× 406 1.2× 239 1.0× 620 3.5× 199 1.2× 74 1.4k
Matthew Schlumbrecht United States 19 295 0.7× 117 0.3× 325 1.4× 221 1.2× 221 1.3× 110 1.0k
Polat Dursun Türkiye 24 573 1.4× 457 1.3× 270 1.1× 584 3.3× 84 0.5× 103 1.5k
Thomas F. Rocereto United States 13 522 1.3× 334 1.0× 283 1.2× 805 4.5× 111 0.7× 21 1.2k

Countries citing papers authored by P. Hanjani

Since Specialization
Citations

This map shows the geographic impact of P. Hanjani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Hanjani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Hanjani more than expected).

Fields of papers citing papers by P. Hanjani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Hanjani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Hanjani. The network helps show where P. Hanjani may publish in the future.

Co-authorship network of co-authors of P. Hanjani

This figure shows the co-authorship network connecting the top 25 collaborators of P. Hanjani. A scholar is included among the top collaborators of P. Hanjani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Hanjani. P. Hanjani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Horowitz, Neil S., Wei Deng, Robert S. Mannel, et al.. (2024). Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279. Journal of Clinical Oncology. 42(16). 1914–1921. 6 indexed citations
2.
Gershenson, David M., Austin Miller, William E. Brady, et al.. (2019). A randomized phase II/III study to assess the efficacy of trametinib in patients with recurrent or progressive low-grade serous ovarian or peritoneal cancer. Annals of Oncology. 30. v897–v898. 42 indexed citations
3.
4.
Schilder, Russell J., Michael W. Sill, Heather A. Lankes, et al.. (2013). A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: A Gynecologic Oncology Group study. Gynecologic Oncology. 129(1). 86–91. 22 indexed citations
5.
Fleming, Gini F., Virginia L. Filiaci, P. Hanjani, et al.. (2011). Hormone therapy plus temsirolimus for endometrial carcinoma (EC): Gynecologic Oncology Group trial #248.. Journal of Clinical Oncology. 29(15_suppl). 5014–5014. 16 indexed citations
6.
Ghaemmaghami, F., et al.. (2006). Successful treatment of two patients with gestational trophoblastic neoplasm presenting with emergent neurologic symptoms. International Journal of Gynecological Cancer. 16(2). 937–940. 2 indexed citations
7.
Ghaemmaghami, F., Maliheh Arab, Nadereh Behtash, et al.. (2004). EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II-IV). International Journal of Gynecological Cancer. 14(2). 360–365. 22 indexed citations
8.
Behtash, Nadereh, et al.. (2004). Borderline ovarian tumours: clinical analysis of 38 cases. Journal of Obstetrics and Gynaecology. 24(2). 157–160. 6 indexed citations
9.
Ghaemmaghami, F., et al.. (2004). Evaluation and management of brain metastatic patients with high-risk gestational trophoblastic tumors. International Journal of Gynecological Cancer. 14(5). 966–971. 14 indexed citations
10.
Behtash, Nadereh, et al.. (2003). Simple hysterectomy in the presence of invasive cervical cancer in Iran. International Journal of Gynecological Cancer. 13(2). 177–181. 12 indexed citations
11.
Behtash, Nadereh, Afsaneh Tehranian, Farid Azmoudeh Ardalan, & P. Hanjani. (2002). Uterine papillary serous carcinoma after pelvic radiation therapy for cancer of the cervix. Journal of Obstetrics and Gynaecology. 22(1). 96–97. 7 indexed citations
12.
Markman, Maurie, Mark F. Brady, Nick M. Spirtos, P. Hanjani, & Stephen C. Rubin. (1998). Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study.. Journal of Clinical Oncology. 16(8). 2620–2624. 110 indexed citations
13.
Williams, Stephen, J A Blessing, S Y Liao, Harrison Ball, & P. Hanjani. (1994). Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group.. Journal of Clinical Oncology. 12(4). 701–706. 222 indexed citations
14.
Lerman, Caryn, P. Hanjani, Suzanne M. Miller, et al.. (1992). Telephone counseling improves adherence to colposcopy among lower-income minority women.. Journal of Clinical Oncology. 10(2). 330–333. 162 indexed citations
15.
Bonomi, Philip, John A. Blessing, Harrison Ball, P. Hanjani, & P.J. DiSaia. (1989). A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix. Gynecologic Oncology. 32(1). 116–116. 1 indexed citations
16.
Valente, Philip T., et al.. (1988). Psammoma bodies in neuroendocrine carcinoma of the uterine cervix.. PubMed. 31(6). 791–5. 15 indexed citations
17.
Stehman, Frederick B., et al.. (1987). Biopsy of the scalene fat pad in carcinoma of the cervix uteri metastatic to the periaortic lymph nodes.. PubMed. 165(6). 503–6. 19 indexed citations
18.
Valente, Philip T. & P. Hanjani. (1986). Endocervical Neoplasia in Long-Term Users of Oral Contraceptives: Clinical and Pathologic Observations. Obstetrics and Gynecology. 67(5). 695–704. 11 indexed citations
19.
Rao, G. S. R. Subba & P. Hanjani. (1986). Secretion of a 97 kilodalton glycoprotein by primary cultures of human ovarian epithelial tumor cells. Cancer Letters. 33(3). 325–332. 2 indexed citations
20.
Hanjani, P., et al.. (1981). Synthesis of catechol estrogens by human uterus and leiomyoma. Steroids. 37(2). 195–203. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katina Robison Breakdown of academic impact, for papers by L. Elit Breakdown of academic impact, for papers by Sarikapan Wilailak Breakdown of academic impact, for papers by Teresa Díaz-Montes Breakdown of academic impact, for papers by Charlotte Gerd Hannibal Breakdown of academic impact, for papers by Berit Jul Mosgaard Breakdown of academic impact, for papers by Corrado Terranova Breakdown of academic impact, for papers by Matthew Schlumbrecht Breakdown of academic impact, for papers by Polat Dursun Breakdown of academic impact, for papers by Thomas F. Rocereto
Rankless by CCL
2026